Bharat Biotech Must Address News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bharat biotech must address. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bharat Biotech Must Address Today - Breaking & Trending Today

NTAGI Approves SII's Covovax COVID-19 Vaccine for 12-17 Age Group: Sources

Earlier this month in an Exclusive Interview with ANI, Serum Institute of India (SII) CEO Adar Poonawalla said, "Covovax will be used for children. It has been approved by DCGI and we re waiting for the Government of India to allow us to put it on the CoWIN app to make it available to everyone." NTAGI Approves SII s Covovax COVID-19 Vaccine for 12-17 Age Group: Sources. ....

New Delhi , Narendra Modi , Adar Poonawalla , Adar Poonawala , Serum Institute Of India Covovax , National Technical Advisory Group On Immunisation , Serum Institute Of India , National Technical Advisory Group , Serum Institute , Prime Minister Narendra Modi , Drugs Controller General , Exclusive Interview , Bharat Biotech Must Address , Covaxin Supply Suspension , Avoid Emergency Use Listing Cancellation , Covid 19 Vaccine , Covovax Vaccine , Cowin App ,

Delhi Reports 1,490 New COVID-19 Cases, 2 Deaths in Past 24 Hours; Positivity Rate at 4.62%

The infection tally in the national capital rose to 18,79,948 and the death toll was 26,172, the bulletin stated. A total of 32,248 COVID-19 tests were conducted in the city on Wednesday, it said. Delhi Reports 1,490 New COVID-19 Cases, 2 Deaths in Past 24 Hours; Positivity Rate at 4.62%. ....

New Delhi , Bharat Biotech Must Address , Covaxin Supply Suspension , Avoid Emergency Use Listing Cancellation , Coronavirus Lockdown , Coronavirus Outbreak , Coronavirus Pandemic , Coronavirus Scare , Coronavirus Variant Xe , Covid 19 Outbreak , Covid 19 Vaccine , Covid 19 Xe Variant , Delta Plus Variant , New Covid 19 Variant Omicron , Xe Covid 19 Variant ,